Výsledky vyhledávání

Phase I trial of CG53135-05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT)

Autor: William F. Hahne, B. Jalilizeinali, V. Annino, S. Possley, John G. Harpel, June Greenberg, Y. Halvorsen, Tsiporah B. Shore, Michael W. Schuster

Publikováno v: Biology of Blood and Marrow Transplantation. 11(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070dbf59135595ca801db053a4b7b66e

Zobrazit plný text záznamu

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

Publikováno v: Biology of Blood and Marrow Transplantation. 12(2):21-22

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24e405fa25533d987055e1e33fbe62c

Zobrazit plný text záznamu

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single dose velafermin (CG53135–05) for the prevention of oral mucositis

Autor: James R. Mason, Michael W. Schuster, V. Annino, William I. Bensinger, William F. Hahne, John M. McCarty, Elias Anaissie, Y. Halvorsen, Richard T. Maziarz, David D. Hurd, Robert M. Rifkin

Publikováno v: Journal of Clinical Oncology. 24:6537-6537

6537 Background: Oral mucositis (OM) is a commonly occurring side effect of high-dose chemotherapy (HDCT) in patients (pts) undergoing autologous hematopoietic stem cell transplant (AHSCT). Velafermin, recombinant human fibroblast growth factor 20, i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6559139b8b96c6c4253eaf6679199077
https://doi.org/10.1200/jco.2006.24.18_suppl.6537

Zobrazit plný text záznamu

Phase I trial of CG53135–05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT)

Autor: Tsiporah B. Shore, Y. Halvorsen, William F. Hahne, V. Annino, S. Possley, Michael W. Schuster, B. Jalilizeinali, June Greenberg

Publikováno v: Journal of Clinical Oncology. 23:6656-6656

6656 Background: Mucositis is a painful side effect of many transplant conditioning regimens. A new class of drugs in the fibroblast growth factor family is being investigated for ameliorating or p...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c674179ac8ac5638a911b8e0e3866717
https://doi.org/10.1200/jco.2005.23.16_suppl.6656

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání